Results 21 to 30 of about 13,589 (222)
Pharmaceutics, 2023 A comparative analysis of the cytostatic effects of progestins (gestobutanoyl, megestrol acetate, amol, dienogest, and medroxyprogesterone acetate), glucocorticoids (hydrocortisone, dexamethasone), and diclofenac on tumor cells was carried out in order ...
Darya Ulchenko +4 more
doaj +1 more source
Depot medroxyprogesterone acetate and breast cancer: a systematic review. [PDF]
Arch Gynecol ObstetPURPOSE Short-acting progestin-only injectables containing depot medroxyprogesterone acetate (DMPA) are a safe method of contraception. Although DMPA has been available for several decades, there is little data on its influence on the risk of breast ...
Zürcher A +3 more
europepmc +3 more sources
Haematologica, 2010 Background Tumor cells in chronic lymphocytic leukemia accumulate in the periphery through the proliferation of a minority of cells in lymph nodes.
Rachel E. Hayden +3 more
doaj +1 more source
National Journal of Physiology, Pharmacy and Pharmacology, 2023 Background: Contraception is the intentional use of artificial methods or other techniques to prevent pregnancy as a consequence of sexual intercourse. Progesterone only injectables are highly effective in preventing in pregnancy as they do not rely on ...
Jayun M Joshi +3 more
doaj +1 more source
Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells [PDF]
, 2021 This document is the Accepted Manuscript version of a published work that appeared in final form in Bioscience Reports. To access the final edited and published work see http://dx.doi.org/10.1042/BSR20202505Drug repurposing is a cost effective means of ...
Ellington, Max A. +9 more
core +1 more source
Subcutaneous depo-medroxyprogesterone acetate [PDF]
Journal of Family Planning and Reproductive Health Care, 2013 Since 2004, a micronised formulation of depo-medroxyprogesterone acetate (DMPA) that is delivered as a subcutaneous injection has been available. It is currently in clinical use in the USA and in nine countries throughout Europe.1 As of March 2013 this product is being marketed in the UK as Sayana® Press (Pfizer, UK).
openaire +2 more sources
Middle East Fertility Society Journal, 2016 Objective: This study was aimed to investigate the effect of combined vitamin C and E on serum leptin, visceral fat mass, and visceral fat oxidative stress in rats treated by depot-medroxyprogesterone acetate (DMPA).
Endang Sri Wahyuni +2 more
doaj +1 more source
Potential Deleterious Effects Following the First Dose of Medroxyprogesterone Acetate as a Contraceptive in Cats [PDF]
Journal of Applied Veterinary Sciences, 2023 The aim of the present work was to investigate the deleterious effects of the first dose of medroxyprogesterone acetate (MPA) on the female genital system of cats.
Ahmed Abdelgalil
doaj +1 more source
The effect of medroxyprogesterone acetate and heparin in the prevention of postsurgical adhesion formation in the rat uterine model [PDF]
, 1999 Objective: To evaluate the effects of depot medroxyprogesterone acetate and heparin in preventing postsurgical adhesion formation in the rat model. Methods: A hundred and five female Wistar rats were divided into 7 groups.
Özşener S. +4 more
core +1 more source
The Association Between Oral Contraceptives, Depot-Medroxyprogesterone Acetate, and Trichomoniasis [PDF]
, 2009 Hormonal contraception use by women may increase the risk of acquiring certain sexually transmitted infections. We explored the effect of hormonal contraceptive use, specifically oral contraception (OC), and depot-medroxyprogesterone acetate (DMPA) on ...
MacDonald, Pia D. M. +13 more
core +2 more sources